Author

Wesley T. Beaulieu

Observed names: Beaulieu, Wesley T., WT Beaulieu, Wesley Beaulieu, Wesley T Beaulieu, Wesley Thomas Beaulieu, WesleyT Beaulieu

Institution: Jaeb Center for Health Research

Observed institutions: Providence College, Indiana University Bloomington, Jaeb Center for Health Research, Indiana University

ORCID: 0000-0002-0082-1242

Observed ORCID: 0000-0002-0082-1242

OpenAlex ID: A5053593038

Conspecific Negative Density Dependence and Forest Diversity

2012 · Daniel J. Johnson, Wesley T. Beaulieu, et al. · Science · 423

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment

2018 · Neil M. Bressler, Wesley T. Beaulieu, et al. · JAMA Ophthalmology · 344

PDF

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity

2019 · Carl W. Baker, Adam R. Glassman, et al. · JAMA · 299

PDF

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

2020 · Adam R. Glassman, John A. Wells, et al. · Ophthalmology · 200

Bioactive alkaloids in vertically transmitted fungal endophytes

2013 · Daniel G. Panaccione, Wesley T. Beaulieu, et al. · Functional Ecology · 190

Bending rules for animal propulsion

2014 · Kelsey N. Lucas, Nathan Johnson, et al. · Nature Communications · 146

PDF

Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy

2020 · Andrew N. Antoszyk, Adam R. Glassman, et al. · JAMA · 132

PDF

Rationale and Application of the Protocol S Anti–Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy

2018 · Jennifer K. Sun, Adam R. Glassman, et al. · Ophthalmology · 120

Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T

2018 · Neil M. Bressler, Wesley T. Beaulieu, et al. · American Journal of Ophthalmology · 113

Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab

2017 · Susan B. Bressler, Wesley T. Beaulieu, et al. · Ophthalmology · 91

Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time

2022 · Dennis M. Marcus, Paolo S. Silva, et al. · JAMA Ophthalmology · 85

Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time

2022 · Paolo S. Silva, Dennis M. Marcus, et al. · JAMA Ophthalmology · 84

Production of the Alkaloid Swainsonine by a Fungal Endosymbiont of the Ascomycete Order Chaetothyriales in the Host Ipomoea carnea

2013 · Daniel Cook, Wesley T. Beaulieu, et al. · Journal of Agricultural and Food Chemistry · 81

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

2023 · Raj K. Maturi, Adam R. Glassman, et al. · JAMA · 66

Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity

2020 · Adam R. Glassman, Carl W. Baker, et al. · JAMA Ophthalmology · 49

PDF

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial

2016 · Wesley T. Beaulieu, Neil M. Bressler, et al. · American Journal of Ophthalmology · 47

Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole

2021 · Clement K. Chan, Calvin E. Mein, et al. · Ophthalmology · 36

Anti–vascular Endothelial Growth Factor Therapy and Risk of Traction Retinal Detachment in Eyes With Proliferative Diabetic Retinopathy

2019 · Neil M. Bressler, Wesley T. Beaulieu, et al. · Retina · 36

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy

2018 · Susan B. Bressler, Wesley T. Beaulieu, et al. · Ophthalmology · 35

Phylogenetic and chemotypic diversity of Periglandula species in eight new morning glory hosts (Convolvulaceae)

2015 · Wesley T. Beaulieu, Daniel G. Panaccione, et al. · Mycologia · 32

Differential Allocation of Seed-Borne Ergot Alkaloids During Early Ontogeny of Morning Glories (Convolvulaceae)

2013 · Wesley T. Beaulieu, Daniel G. Panaccione, et al. · Journal of Chemical Ecology · 32

Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy

2021 · Maureen G. Maguire, Danni Liu, et al. · JAMA Ophthalmology · 31

Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema

2023 · David W. Hutton, Adam R. Glassman, et al. · JAMA Ophthalmology · 28

Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular Degeneration

2023 · Kevin J. Blinder, Claire Calhoun, et al. · Ophthalmology Retina · 27

Quantification of flows generated by the hydromedusa Aequorea victoria: a Lagrangian coherent structure analysis

2011 · K Katija, WT Beaulieu, et al. · Marine Ecology Progress Series · 27

PDF

Works count: 63

Citation count: 2,941

H-index: 26

I10-index: 31